Peer Review History

Original SubmissionJuly 11, 2019
Decision Letter - Russell Kabir, Editor

PONE-D-19-19653

Comparability of modern contraceptive use estimates between a face-to-face survey and a cellphone survey among women in Burkina Faso

PLOS ONE

Dear Mr. Greenleaf,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we have decided that your manuscript does not meet our criteria for publication and must therefore be rejected.

Specifically: there is lack of consistent information, at some places the statements are not clearly presented. The findings and the interpretation of data dont match and variables used in the research are not clearly defined.

I am sorry that we cannot be more positive on this occasion, but hope that you appreciate the reasons for this decision.

Yours sincerely,

Russell Kabir, PhD

Academic Editor

PLOS ONE

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Partly

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: No

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: No

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: There are few comments as well such as:

1- What are the information in first column? Are they age categories?

2- Page 15, line 317, “significance using an alpha of 0.05” should be written “less than 0.05”.

3- Page 20, line 347, please include SD or SE when you report the mean.

4- Table 4, please clarify different marital status as married and non-married.

5- Table 5 can be deleted as its information has been explained in text completely.

6- Table 6, some figured are bold which probably shows the significance but p-value is not reported.

7- Discussion should show the application of the study results.

Reviewer #2: The authors present an important issue relevant for public health and epidemiological data collection. In the present article, the main aim was to assess survey errors when comparing computer assisted telephone interviews (CATI) to FTF surveys for modern contraceptive use in Burkina Faso. As the first of its kind, this paper is essential given the recent increase in cell phone ownership in low to middle income countries (LMIC). I commend their brilliant presentation and recommend this article to be considered for publication.

My only comment relating to this article is given below:

The authors clearly pointed out that the difference in contraceptive prevalence rates could not be fully explained owing in part to the small number of demographic variables available in the RDD survey. Other key indicators that influence the use of modern contraceptives in LMIC settings include the health service environment, physical infrastructure, and prevailing cultural beliefs surrounding health care seeking. Were any of these assessed as part of the study? It will be interesting to see how any of these other indicators contribute to the difference in prevalence rates between the two surveys.

Reviewer #3: I do not think the manuscript is written in a scientific manner and there is a lack of consistency across the manuscript. The comparison of both data and their interpretations are difficult to understand. Moreover, this is not a suitable manuscript for Plos One readers.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

Reviewer #3: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files to be viewed.]

- - - - -

For journal use only: PONEDEC3

Revision 1

Please find response to Reviewers 1-3, and the Academic Editor. I am submitting after receiving approval for an appeal and re-submission.

Reviewer #1:

1- What are the information in first column? Are they age categories?

Thank you for your careful attention to Table 1. Yes, this column is age groups. I have changed the column heading accordingly. Line 159

2- Page 15, line 317, “significance using an alpha of 0.05” should be written “less than 0.05”.

We have made this change. Line 310

3- Page 20, line 347, please include SD or SE when you report the mean.

We added the standard error to the text that refers to average age. Line 341

4- Table 4, please clarify different marital status as married and non-married.

We prefer to refer to our respondents as “in union” or “not in union” as in the setting (Burkina Faso) many people may not be married but are co-habiting, which we refer to as “in union” because they are not legally married. We will keep this classification as is, as this is also the classification the Demographic and Health Survey uses, which is our reference standard. Lines 276, 277 and Table 4.

5- Table 5 can be deleted as its information has been explained in text completely.

Point well taken. I have deleted Table 5.

6- Table 6, some figured are bold which probably shows the significance but p-value is not reported.

We have added a footnote at the bottom of the table that the bold denotes statistical significance less than 0.05. We report the confidence intervals instead of the p-value as we find the confidence interval to be more telling information than the p-value. Table 6.

7- Discussion should show the application of the study results.

We added a more explicit explanation of the application of study results in two areas of the discussion section: lines 411 – 414 & lines 464 – 466.

Reviewer #2:

The authors present an important issue relevant for public health and epidemiological data collection. In the present article, the main aim was to assess survey errors when comparing computer assisted telephone interviews (CATI) to FTF surveys for modern contraceptive use in Burkina Faso. As the first of its kind, this paper is essential given the recent increase in cell phone ownership in low to middle income countries (LMIC). I commend their brilliant presentation and recommend this article to be considered for publication.

My only comment relating to this article is given below:

The authors clearly pointed out that the difference in contraceptive prevalence rates could not be fully explained owing in part to the small number of demographic variables available in the RDD survey. Other key indicators that influence the use of modern contraceptives in LMIC settings include the health service environment, physical infrastructure, and prevailing cultural beliefs surrounding health care seeking. Were any of these assessed as part of the study? It will be interesting to see how any of these other indicators contribute to the difference in prevalence rates between the two surveys.

Thank you for your feedback. Unfortunately we did not collect data on key indicators you mention above. We added a sentence in the discussion section about how these variables could better explain the difference in our outcomes of interest. See lines 448-450.

Reviewer #3:

I do not think the manuscript is written in a scientific manner and there is a lack of consistency across the manuscript. The comparison of both data and their interpretations are difficult to understand. Moreover, this is not a suitable manuscript for Plos One readers.

Academic Editor:

1) There is lack of consistent information

This statement does not provide details about where there is perceived inconsistent information

2) At some places the statements are not clearly presented

This statement does not provide details about where there is perceived inconsistent information

3) The findings and the interpretation of data don’t match

This statement does not provide details about where there is perceived inconsistent information

4) Variables used in the research are not clearly defined

The AAPOR variables used (Subheading “Measure – defining call outcomes from RDD survey using AAPOR final disposition codes”) follow the same guidelines as used by L’Engle et al. published by PLOSOne in 2018. Furthermore, the outcome variables also follow the AAPOR guidelines.

The dependent variable, modern contraceptive use, follows the definition of modern contraceptive use given by the Demographic and Health Survey, which is the reference standard. The independent variables, which are commonly used socio-demographic variables, are defined between lines 272 – 279.

Attachments
Attachment
Submitted filename: Plos ONE Reviewer comment responses_2Dec2019.docx
Decision Letter - Kenneth Ngure, Editor

Comparability of modern contraceptive use estimates between a face-to-face survey and a cellphone survey among women in Burkina Faso

PONE-D-19-19653R1

Dear Dr.  Abigail Greenleaf,  

After reviewing your manuscript, your appeal and all reviewer comments, we are pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it complies with all outstanding technical requirements.

Within one week, you will receive an e-mail containing information on the amendments required prior to publication. When all required modifications have been addressed, you will receive a formal acceptance letter and your manuscript will proceed to our production department and be scheduled for publication.

Shortly after the formal acceptance letter is sent, an invoice for payment will follow. To ensure an efficient production and billing process, please log into Editorial Manager at https://www.editorialmanager.com/pone/, click the "Update My Information" link at the top of the page, and update your user information. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to enable them to help maximize its impact. If they will be preparing press materials for this manuscript, you must inform our press team as soon as possible and no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

With kind regards,

Kenneth Ngure, PhD MPH

Academic Editor

PLOS ONE

Tanya Doherty PhD

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please include additional information regarding the survey or questionnaire used in the RDD study and ensure that you have provided sufficient details that others could replicate the analyses. For instance, if you developed a questionnaire as part of this study and it is not under a copyright more restrictive than CC-BY, please include a copy, in both the original language and English, as Supporting Information.

2. Please note that in order to use the direct billing option the corresponding author must be affiliated with the chosen institute. Please either amend your manuscript or remove this option (via Edit Submission).

3. Please amend your list of authors on the manuscript to ensure that each author is linked to an affiliation. Authors’ affiliations should reflect the institution where the work was done (if authors moved subsequently, you can also list the new affiliation stating “current affiliation:….” as necessary).

4. Thank you for including your ethics statement on the online submission form:

"The PMA2020 FTF survey has exempt status (IRB #00000287, exempt as “public health practice”, defined by DHHS regulations 45 CFR 46.102), as determined by John Hopkins’ IRB. Approval was granted in July 2014 by the Comité d’éthique pour la recherche en santé (IRB #2014-7-81). Consent was obtained orally. For the phone survey, ethical approval was granted by the IRB at the Johns Hopkins Bloomberg School of Public Health (IRB No. 00007961). The ISSP team submitted a protocol to their ethical committee for the RDD survey (IRB No. 2018-3-036).".

* To help ensure that the wording of your manuscript is suitable for publication, would you please also add this statement at the beginning of the Methods section of your manuscript file.

Formally Accepted
Acceptance Letter - Kenneth Ngure, Editor

PONE-D-19-19653R1

Comparability of modern contraceptive use estimates between a face-to-face survey and a cellphone survey among women in Burkina Faso

Dear Dr. Greenleaf:

I am pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please notify them about your upcoming paper at this point, to enable them to help maximize its impact. If they will be preparing press materials for this manuscript, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

For any other questions or concerns, please email plosone@plos.org.

Thank you for submitting your work to PLOS ONE.

With kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Kenneth Ngure

Academic Editor

PLOS ONE

Open letter on the publication of peer review reports

PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.

We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.

Learn more at ASAPbio .